{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:52Z","timestamp":1781528152178,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005689","name":"G\u00f6teborg Medical Society","doi-asserted-by":"publisher","award":["GLS-1001019"],"award-info":[{"award-number":["GLS-1001019"]}],"id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009791","name":"Apotekare Hedbergs Foundation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008448","name":"Rune and Ulla Aml\u00f6vs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010107","name":"Anna-Lisa and Bror Bj\u00f6rnssons Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107163","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:39:25Z","timestamp":1774514365000},"page":"107163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7151-201X","authenticated-orcid":false,"given":"Magnus","family":"Johnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynhildur","family":"Hafsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clas","family":"Malmestr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107163_bib0001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2009.09.006","article-title":"Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis","volume":"216","author":"Berg-Hansen","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107163_bib0003","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(98)00263-8","article-title":"Serum levels of macrophage-derived protein MRP-8\/14 are elevated in active multiple sclerosis","volume":"247","author":"Bogumil","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2026.107163_bib0004","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","article-title":"Monocyte\/macrophage differentiation in early multiple sclerosis lesions","volume":"38","author":"Br\u00fcck","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0005","first-page":"733","article-title":"Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases","volume":"21","author":"Brun","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.msard.2026.107163_bib0006","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474124.2014.869476","article-title":"The use of fecal calprotectin as a biomarker in gastrointestinal disease","volume":"8","author":"Burri","year":"2014","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.msard.2026.107163_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-021-00244-5","article-title":"Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on \u201cChemokine CXCL13 in serum, CSF, and blood\u2013CSF barrier function","volume":"18","author":"DiSano","year":"2021","journal-title":"Fluids. Barriers. CNS."},{"issue":"6","key":"10.1016\/j.msard.2026.107163_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00365549109024294","article-title":"Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection?","volume":"23","author":"Dunlop","year":"1991","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.msard.2026.107163_bib0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2003.11.005","article-title":"Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8\/14 levels","volume":"148","author":"Floris","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107163_bib0010","article-title":"Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis","author":"Furlan","year":"2025","journal-title":"Brain (London, England : 1878)"},{"issue":"8","key":"10.1016\/j.msard.2026.107163_bib0011","article-title":"A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation","volume":"10","author":"Gaetani","year":"2018","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.msard.2026.107163_bib0012","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-020-01874-6","article-title":"Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis","volume":"17","author":"Gong","year":"2020","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2026.107163_bib0013","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1352458516669002","article-title":"Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"23","author":"Hakobyan","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107163_bib0014","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106302","article-title":"The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use","volume":"94","author":"Johnsson","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107163_bib0016","article-title":"Cerebrospinal fluid alpha-internexin is increased in patients with multiple sclerosis and correlates strongly with neurofilament light protein","volume":"104","author":"Johnsson","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107163_bib0017","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications","volume":"89","author":"Kaneko","year":"2018","journal-title":"J. Neurol., Neurosurg. amp; Psychiatry"},{"key":"10.1016\/j.msard.2026.107163_bib0018","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cbpa.2009.11.008","article-title":"Nutritional immunity beyond iron: a role for manganese and zinc","volume":"14","author":"Kehl-Fie","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.msard.2026.107163_bib0019","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jnnp-2022-330796","article-title":"Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis","volume":"94","author":"Leppert","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107163_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94995-8","article-title":"Inflammatory markers and risk of cardiovascular mortality in relation to diabetes status in the HUNT study","volume":"11","author":"L\u00f8fblad","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107163_bib0021","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102520","article-title":"Biomarkers of inflammation and epithelial barrier function in multiple sclerosis","volume":"46","author":"Olsson","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107163_bib0023","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1111\/febs.15803","article-title":"Roles of neutrophil granule proteins in orchestrating inflammation and immunity","volume":"289","author":"Othman","year":"2022","journal-title":"FEBS. J."},{"key":"10.1016\/j.msard.2026.107163_bib0024","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.msard.2026.107163_bib0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults","volume":"51","author":"Rosengren","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.msard.2026.107163_bib0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0027","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.3390\/ijms26136476","article-title":"Calprotectin as a biomarker for infectious diseases: a comparative review with conventional inflammatory markers","volume":"26","author":"Sejersen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107163_bib0028","article-title":"Value of cerebrospinal fluid calprotectin assay in patients with acute meningitis","author":"Shozan","year":"2022","journal-title":"Med. J. Cairo Univ."},{"key":"10.1016\/j.msard.2026.107163_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1598885","article-title":"The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/296149","article-title":"Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux","volume":"2015","author":"Tardif","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.msard.2026.107163_bib0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0032","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107163_bib0033","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107163_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:25:11Z","timestamp":1781526311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S2211034826001999"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107163","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107163"}}